About Portage Biotech, Inc. Portage Biotech is a clinical-stage immuno-oncology company advancing a pipeline of novel biologics to transform the immune system’s ability to fight cancer. For more ...

Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-8, a dual ...

Not only new vulnerabilities are being actively exploited by cybercriminals. Hackers still manage to find two vulnerabilities ...

Portage Biotech stock is trading higher after the company announced it signed a letter of intent with Immunova for the potential sale of its subsidiary.

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

The US IT security authority CISA warns of recently observed attacks in the wild on vulnerabilities in Linux, Apache OFBiz, Microsoft's .Net framework and Paessler PRTG. IT managers should ...

There are no SEC filings that match your filter(s), please update your selections to return more records. Nasdaq provides company’s SEC filings, which are financial statements and reports filed ...